Evidence map›Paper›PMID 28835582›Full record

ReviewJournal of atherosclerosis and thrombosis2017

n-3 Polyunsaturated Fatty Acids: Promising Nutrients for Preventing Cardiovascular Disease.

Shusuke Yagi, Daiju Fukuda, Ken-Ichi Aihara, Masashi Akaike, Michio Shimabukuro, Masataka Sata

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in Journal of atherosclerosis and thrombosis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06129526 (Study of the Effect of Eicosapentaenoic Acid), which is not on this map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06129526 phase4unknown statusnot on this mapstarted 2023, after this paper: background citation

Study of the Effect of Eicosapentaenoic Acid (EPA) on Markers of Atherothrombosis in Patients With Type-2 Diabetes

TypeinterventionalSponsorUniversity of IoanninaRan2023 to 2024Enrolled450ConditionsDiabetes Type 2, Hypertriglyceridemia, Diabetes MellitusArmsEPAVasc, Corn Oil
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Omega-3 Polyunsaturated Fatty Acids in Depression.International journal of molecular sciences · 2024
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Peruvian Amaranth (International journal of molecular sciences · 2023
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Shusuke YagiDepartment of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences.
Daiju FukudaDepartment of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences.
Ken-Ichi AiharaDepartment of Community Medicine for Diabetes and Metabolic Disorders, Tokushima University Graduate School of Biomedical Sciences.
Masashi AkaikeDepartment of Medical Education, Tokushima University Graduate School of Biomedical Sciences.
Michio ShimabukuroDepartment of Cardio-Diabetes Medicine, Tokushima University Graduate School of Biomedical Sciences.
Masataka SataDepartment of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences.
Tokushima University · JPFukushima Medical University · JPShikoku Central Hospital of the Mutual Aid Association of Public School Teachers · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The adoption of the Western-style diet, with decreased fish intake and lack of exercise, has increased the prevalence of cardiovascular disease (CVD) in Japan. Statin treatment has been established to reduce the risk of cardiovascular events; however, 60%-70% of these events occur despite its use. Thus, the residual risk for CVD should be identified and resolved to reduce further cardiovascular events. The serum levels of n-3 polyunsaturated fatty acids (PUFAs), including eicosapentaenoic acid and docosahexaenoic acid, are reportedly associated with an increased incidence of cardiovascular events and mortality, whereas the addition of n-3 PUFA treatment to the statin treatment decreases cardiovascular events. Similar to statins, n-3 PUFAs have pleiotropic effects in addition to lipid-modifying effects. Pre-clinical and clinical studies have shown that n-3 PUFAs prevent cardiovascular events by ameliorating endothelial function and attenuating lipid accumulation, vascular inflammation, and macrophage recruitment, thereby causing coronary plaque development and rupture. Taken together, n-3 PUFAs are comprehensively able to attenuate the atherogenic response. Therefore, n-3 PUFA intake is recommended to prevent cardiovascular events, particularly in patients with multiple cardiovascular risk factors.

Indexed as

Cardiovascular DiseasesCell MovementCell ProliferationDocosahexaenoic AcidsEicosapentaenoic AcidEndothelium, VascularFatty Acids, Omega-3FoodHumansHydroxymethylglutaryl-CoA Reductase InhibitorsInflammationMacrophagesPlaque, AtheroscleroticRandomized Controlled Trials as TopicRisk FactorsDocosahexaenoic AcidsEicosapentaenoic AcidFatty Acids, Omega-3Hydroxymethylglutaryl-CoA Reductase InhibitorsCardiovascular diseaseDocosahexaenoic acidEicosapentaenoic acidResidual risk

Identifiers

PMID28835582
PMCPMC5656772
OpenAlexW2748760644

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.